Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Cavion
600 East Water Street, Suite E
Charlottesville, VA 22902
Phone: 434-200-8442
http://cavionpharma.com/

Cavion, Inc. is a privately held clinical stage biotechnology company creating therapies modulating the T-type calcium channel (Cav3) for the treatment of neurological and oncologic diseases. Cavion is co-sponsoring a Phase 1 trial of mibefradil combined with hypofractionated radiation therapy for the treatment of recurrent glioblastoma multiforme with the Yale University Comprehensive Cancer Center.

Key Contact
NameTitleE-Mail
Andrew KrouseCEOkrouse@cavionpharma.com


Funding Events
DateAmountTypeInvestors
01/06/17$26,100,000Series A Enso Ventures
Lilly Ventures
Novartis Venture Funds
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.